Please Share::
�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��
��
-->
�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��
��
Resilient performance
Pidilite’s 2QFY15 revenues grew by a robust 14% to
Rs 12.5bn (despite high base), led by 10% YoY volume
growth. However, on the negative front, EBITDA
margin contracted 81bps to 16.4% led by higher
COGS and staff costs. The Consumer & Bazaar
segment witnessed 221bps YoY EBIT margin
contraction. Aided by higher other income and lower
finance costs and tax rate, APAT grew 13.3% YoY to
Rs 1.4bn.
We remain enthused by Pidilite’s improving product
mix, R&D capability and distribution network. In
addition, almost 60% of Pidilite’s portfolio will be
positively impacted from the anticipated recovery in
macro environment. We like Pidilite’s superior
quality and high growth business. However,
valuations are rich. Retain NEUTRAL with a TP is Rs
435 (27x FY17E).
EBITDA margin contracts, recovery likely
Despite an adverse base (2QFY14 : 21.6% YoY),
operating revenues grew 14.0% YoY (10% volume led).
EBITDA margin contracted 81bps led by higher COGS
(+65bps) and staff costs (+33bps). This was partially
offset by lower other expenditure (-17bps).
Domestic gross margin declined 107bps YoY on account
of higher VAM prices (up 45% YoY) and YoY INR
depreciation in 2QFY15. As per the management, VAM
prices have peaked (VAM prices have corrected by 1%
each in August and September). Furthermore, the price
hike initiated in May-2014 (3-3.5%) and August-2014
(3-4%) and stable INR would fully reflect in 2HFY15.
This along with reduction in freight (due to lower diesel
prices) would benefit EBITDA margins.
Consumer & Bazaar had a tough quarter
Impacted by a high base, Consumer & Bazaar sales
grew 15.1% YoY (vs 20.7% in 1QFY15) to Rs 10.3bn with
EBIT margin declining 221bps. Higher VAM prices in
2QFY15 and higher depreciation hurt EBIT margins.
Industrial segment (moderation in exports) revenues
grew 7.7% to Rs 2.3bn as EBIT margin remained flat YoY
to 11.5% bps. Price hikes (3-4%) aided margins.
International subsidiaries grew a mere ~5% YoY (6.3%
in const currency) due to weakness in Brazil and US.
Valuations and views
As we roll forward our earnings to FY17, we raise our
TP to Rs 435 (27x FY17E). Retain NEUTRAL.
LINK
http://www.hdfcsec.com/Share-Market-Research/Research-Details/StockReports/3009610
No comments:
Post a Comment